Patents by Inventor Sabina Christ

Sabina Christ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNA-biomarkers for diagnosis of prostate cancer
    Patent number: 10301683
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumor cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: May 28, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • RNA-biomarkers for diagnosing prostate cancer
    Patent number: 10287634
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumor cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: May 14, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWAND
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • RNA-biomarkers for diagnosis of prostate cancer
    Patent number: 10196695
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: February 5, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • RNA-biomarkers for diagnosis of prostate cancer
    Patent number: 10196696
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: February 5, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWAND
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKER SIGNATURE FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20170362662
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2015
    Publication date: December 21, 2017
    Applicant: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKERS FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20160312291
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 27, 2016
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKERS FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20160304967
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 20, 2016
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKERS FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20160304965
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 20, 2016
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKERS FOR DIAGNOSING PROSTATE CANCER
    Publication number: 20160304966
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 20, 2016
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKERS FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20160298199
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 13, 2016
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel